Common Stock, Par or Stated Value Per Share in USD/shares of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: GBP/shares and USD/shares
Description
Face amount or stated value per share of common stock.
Summary
Achilles Therapeutics plc quarterly Common Stock, Par or Stated Value Per Share history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Common Stock, Par or Stated Value Per Share for the quarter ending 30 Jun 2024 was 0 USD/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Common Stock, Par or Stated Value Per Share (USD/shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0 $0 0% 30 Jun 2024 6-K 14 Aug 2024
Q1 2024 $0 $0 0% 31 Mar 2024 6-K 14 Aug 2024
Q4 2023 $0 $0 0% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 $0 $0 0% 30 Jun 2023 6-K 14 Aug 2024
Q1 2023 $0 $0 0% 31 Mar 2023 6-K 14 Aug 2024
Q4 2022 $0 $0 0% 31 Dec 2022 20-F 04 Apr 2024
Q2 2022 $0 30 Jun 2022 6-K 04 Aug 2023
Q1 2022 $0 31 Mar 2022 6-K 04 Aug 2023
Q4 2021 $0 $0 0% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 $0 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.